Legislation introduced by Utah Senator Mike Lee would eliminate testing to show a biosimilar can be substituted for a reference biologic product. Lee contends the current testing requirement adds costs and delays market access for these lower-cost biological medicines.
AHA’s report comes after the U.S. House of Representatives passed the Improving Seniors’ Timely Access to Care Act, which would establish several requirements for the prior authorization process under MA plans. But AHA believes additional action is needed by the government.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
To achieve diversity goals in research requires a multifaceted approach that makes clinical trial participation easier and uses analytics to help identify the right patients to recruit for a clinical trial.
The onus is on providers, payers and their technology partners to use the new laws and market dynamics as a catalyst to fully achieve digital transformation in healthcare and improve the patient experience.
This legislation has the potential to drastically reshape the economics of healthcare in America, but it remains unfamiliar to those it affects most—namely, patients, doctors and outpatient surgery centers.
Not all drugs will be subject to price negotiation under the revised legislation. But the agreement sets up a framework enabling Medicare to negotiate the prices of medicines that have been on the market for a long time, and also caps the monthly price of insulin, which has been a flashpoint of drug price debate.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The bill, if enacted into law, will establish an electronic prior authorization process and require Medicare Advantage plans to report on their use of prior authorization and the rate of approvals or denials to CMS. It has 227 co-sponsors in the U.S. House, indicating strong support from both Republicans and Democrats.
The increase in access to public health insurance coverage — via legislation like the Families First Coronavirus Response Act that prevents states from disenrolling Medicaid beneficiaries — helped offset the loss of employer-sponsored insurance, the report from Robert Wood Johnson Foundation shows.
Several states passed recent laws that would require commercial insurance plans to cover more telehealth services on a permanent basis. More states now require health plans to pay the same amount for telehealth as in-person visits.
Governor Andrew Cuomo plans to launch a website where patients can compare the cost of procedures at hospitals around the state.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Mental health advocates have described it as the most significant piece of mental health legislation since the 2008 law requiring equal insurance coverage for mental and physical health.
The 21st Century Cures Act, an ambitious bipartisan bill primarily designed to advance medical science and accelerate the introduction of innovative therapeutics to market, cleared the Senate Wednesday.
The bill is a grab bag for industries that spent plenty of money lobbying to make sure it happened that way.
Other than major appropriations bills, a transportation spending bill and an energy infrastructure funding bill, the 21st Century Cures Act garnered more lobbying activity than any of the more than 11,000 bills proposed in the 114th Congress.
Topping the list of ACA provisions likely to survive under Trump is the requirement that employers cover workers’ children up to the age of 26, analysts said.